APA (7th ed.) Citation

Jia, N., Bao, Z., Zhang, Z., Wang, K., & Li, Y. (2026). A new paradigm for retroperitoneal leiomyosarcoma: Integrating transcriptomic subtyping and surgical risk stratification for AI-guided drug repurposing. Oncology Reviews, 1. https://doi.org/10.3389/or.2026.1744721

Chicago Style (17th ed.) Citation

Jia, Nan, Zicheng Bao, Zhidong Zhang, Kaixing Wang, and Yong Li. "A New Paradigm for Retroperitoneal Leiomyosarcoma: Integrating Transcriptomic Subtyping and Surgical Risk Stratification for AI-guided Drug Repurposing." Oncology Reviews 2026: 1. https://doi.org/10.3389/or.2026.1744721.

MLA (9th ed.) Citation

Jia, Nan, et al. "A New Paradigm for Retroperitoneal Leiomyosarcoma: Integrating Transcriptomic Subtyping and Surgical Risk Stratification for AI-guided Drug Repurposing." Oncology Reviews, 2026, p. 1, https://doi.org/10.3389/or.2026.1744721.